Cargando…
Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models
There is no doubt that cell signaling manipulation is a key strategy for anticancer therapy. Furthermore, cell state determines drug response. Thus, establishing the relationship between cell state and therapeutic sensitivity is essential for the development of cancer therapies. In the era of person...
Autores principales: | Stulpinas, Aurimas, Sereika, Matas, Vitkeviciene, Aida, Imbrasaite, Ausra, Krestnikova, Natalija, Kalvelyte, Audrone V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848735/ https://www.ncbi.nlm.nih.gov/pubmed/36686779 http://dx.doi.org/10.3389/fonc.2022.1045521 |
Ejemplares similares
-
Crosstalk between ERK, AKT, and cell survival
por: Dent, Paul
Publicado: (2014) -
Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019) -
What Does the “AKT” Stand for in the Name “AKT Kinase”? Some Historical Comments
por: Xie, Jiuyong, et al.
Publicado: (2020) -
Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling
por: Wang, Wei, et al.
Publicado: (2021) -
IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
por: Wang, Xiaomeng, et al.
Publicado: (2019)